NCT06000813Completed
REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
Latino individuals, the fastest growing ethnic minority population in the United States, have a higher prevalence of type 2 diabetes and diabetes-related complications, and are more likely to report inconsistent use of diabetes medications than non-Hispanic White individuals. The proposed project will test an interactive text message-based tool tailored to address barriers to taking diabetes medications that are relevant to Latino adults. If found feasible, acceptable, and usable, this intervention could serve as a scalable tool to improve diabetes management and reduce diabetes-related complications among Latino adults in the United States.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 4 Aug 2023
- Start date
- 18 Jun 2024
- Primary completion date
- 27 May 2026
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Type 2 diabetes
- NCT number
- NCT06000813
What you commit to
- Study type: Interventional
- Participants enrolled: 70
- From 18 Jun 2024 to the primary completion date, 27 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Auditory limitations and/or inability to communicate orally
- Inability to receive, read, or send a text message (assessed by a trained research assistant)
Who the study is looking for
- Type 2 diabetes mellitus
- Have current or prior (since 2018) HbA1c ≥8.0%
- Take at least one diabetes medication
- Receive care at MGH- affiliated primary care practices (≥2 visits in the past 3 years)
- ≥18 yrs
- Identify as Latino and/or Hispanic
- Speak and read in Spanish as preferred language
- Willing and able to provide informed consent
- Access to a mobile telephone with text messaging capability
- Suboptimal diabetes medication adherence, assessed using the first 2 items in the Adherence to Refill and Medication Scale (ARMS-d) questionnaire combined: "How frequently do you forget or decide to not take your diabetes medications?" Participants who answer sometimes, almost always, and/or always will be considered eligible for the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Diabetes Research Center Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.